2026-10-19T01:56:10Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/151832026-10-18T21:14:29Zopenairedrivercom_ebyu_10000col_ebyu_10001

Distal phalangeal necrosis in the extremities as a paraneoplastic syndrome in prostate cancer: An extremely rare caseAkin, YigitYucel, SelcukBaykara, MehmetGangreneParaneoplastic syndromeProstate cancerAmputationAndrogen AntagonistsAntineoplastic Agents, HormonalDisease ProgressionFinger PhalangesHumansMaleMiddle AgedNecrosisNeoplasm GradingNeoplasm StagingParaneoplastic SyndromesProstatic NeoplasmsToe PhalangesTreatment Outcomecalcium channel blocking agentglucocorticoidlow molecular weight heparinprostate specific antigenantiandrogenantineoplastic hormone agonists and antagonistsadultandrogen deprivation therapyArticlebone necrosiscancer stagingcase reportParaneoplastic syndromes (PNSs) are rare disorders which are triggered by an altered immune system response to a neoplasm. Although prostate cancer (PCa) is the second most common urological malignancy associated with PNSs, literature is lacking in defining the cases representing different PNSs in PCa. Herein, we present a 50-year-old man with fulminant distal phalangeal necrosis in the lower extremities after a diagnosis of PCa. Additionally, we review the literature in light of this case. © 2013 S. Karger AG, Basel.S. Karger AG2014Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/15183https://doi.org/10.1159/0003546480042-1138enUrologia Internationalisinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/15183